Petros Pharmaceuticals, Inc.
Drug Manufacturers - Specialty & Generic • Healthcare • New York, NY, United States • PTPI (PNK)
Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary SaaS platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.
Stock Performance (90 Days)
Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).
Layoff History
No layoff events recorded for this company.
Recent News
Petros Pharmaceuticals to appeal Nasdaq delisting decision - Investing.com
Investing.com • May 21
Petros Pharmaceuticals to be Delisted from Nasdaq - TipRanks
TipRanks • Nov 7
Petros Pharmaceuticals Announces Transition from NASDAQ to OTC Markets - ACCESS Newswire
ACCESS Newswire • May 21
Petros Pharma Stock Plunges To Record Low On 1-For-25 Reverse Split, But Retail Optimism Lingers - Stocktwits
Stocktwits • May 1
Aug Patterns: Will Petros Pharmaceuticals Inc. stock see insider buying - Market Activity Summary & Weekly Top Gainers Alerts - Bölüm Sonu Canavarı
Bölüm Sonu Canavarı • Dec 19
Other Drug Manufacturers - Specialty & Generic Companies
View All →
Frequently Asked Questions
Has Petros Pharmaceuticals, Inc. had layoffs?
No layoff events have been recorded for Petros Pharmaceuticals, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Petros Pharmaceuticals, Inc. have?
Petros Pharmaceuticals, Inc. has approximately 18 employees.
What industry is Petros Pharmaceuticals, Inc. in?
Petros Pharmaceuticals, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, within the Healthcare sector.
Is Petros Pharmaceuticals, Inc. a publicly traded company?
Yes, Petros Pharmaceuticals, Inc. is publicly traded under the ticker symbol PTPI on the PNK. The company has a market capitalization of approximately $0.00 billion.
Where is Petros Pharmaceuticals, Inc. headquartered?
Petros Pharmaceuticals, Inc. is headquartered in New York, NY, United States at 1185 Avenue of the Americas, New York, NY 10036, United States.
Disclaimer
Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.
This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.
Found an error? Report it here.